Stage IV CD30+ anaplastic large cell lymphoma: Response to acitretin and interferon-α

Australasian Journal of Dermatology

Volumn 43, Issue 3, 2002, Pages 207-210

  Ong, Colin ^a,b   Sullivan, John ^a   Hertzberg, Mark ^a   Stapleton, Karen ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b Macquarie Center   (Australia)

Author keywords

Cytokine; Ki 1 lymphoma; Metastatic; Methotrexate; Rheumatoid arthritis

Indexed keywords

ALPHA INTERFERON; CD30 ANTIGEN; ETRETIN; METHOTREXATE;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; BRAIN LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LUNG CARCINOMA; RHEUMATOID ARTHRITIS; SKIN LYMPHOMA; TREATMENT OUTCOME;

ACITRETIN; ADMINISTRATION, ORAL; ANTIGENS, CD30; ANTINEOPLASTIC AGENTS; ARM; BIOPSY, NEEDLE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; INTERFERON-ALPHA; KERATOLYTIC AGENTS; LYMPHOMA, LARGE-CELL, KI-1; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; SKIN ULCER; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0036062117     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-0960.2002.00597.x     Document Type: Article

References (16)

1. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment
2. Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study of 47 patients
3. CD30/Ki-1-positive lymphoproliferative disorders of the skin - Clinicopathologic correlation and statistical analysis of 86 cases: A multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group
4. Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot study
5. Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid
6. Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug-resistance phenotypes
7. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
8. Cancer chemoprevention
9. Retinoids and interferons in non-melanoma skin cancer
10. Recombinant IFN-alpha in lymphomas
11. Retinoids and interferon: A new promising combination?
12. Prospective randomized multicenter clinical trial on the use of interferon-2a plus acitretin versus interferon-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II
13. Response of Epstein-Barr virus-associated Ki-1+ anaplastic large cell lymphoma to 13-cis retinoic acid and interferon alpha
14. A novel chemotherapeutic regimen (interferon alfa, zidovudine, and etretinate) for adult T-cell lymphoma resulting in rapid tumor destruction
15. Lymphoma in patients with rheumatoid arthritis: Association with the disease state or methotrexate treatment
16. Lymphoma and leukemia in rheumatoid arthritis. A matched case-control study in the ARAMIS (Arthritis, Rheumatism and Aging Medical Information System) population